Lemaitre Vascular (LMAT) EBITDA Margin Growth (3y) (2013 - 2026)
Powered by 
Analysis
Lemaitre Vascular (LMAT) EBITDA Margin Growth (3y) (2013 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn | -201.00 |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn | 722.00 |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn | 162.00 |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn | 586.00 |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | 736.00 |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | 887.00 |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn | -1,075.00 |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn | 963.00 |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | 244.00 |
| 10 | Lemaitre Vascular | 1.80 Bn | 1.43 Bn | 50.76 Mn | 1,012.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1,012.00 |
| Mar 31, 2026 | 998.00 |
| Dec 31, 2025 | 1,221.00 |
| Sep 30, 2025 | 1,752.00 |
| Jun 30, 2025 | 1,139.00 |
| Mar 31, 2025 | 105.00 |
| Dec 31, 2024 | 206.00 |
| Sep 30, 2024 | 34.00 |
| Jun 30, 2024 | -156.00 |
| Mar 31, 2024 | 6.00 |
| Dec 31, 2023 | -454.00 |
| Sep 30, 2023 | -815.00 |
| Jun 30, 2023 | -74.00 |
| Mar 31, 2023 | 248.00 |
| Dec 31, 2022 | 68.00 |
| Sep 30, 2022 | -453.00 |
| Jun 30, 2022 | -633.00 |
| Mar 31, 2022 | 447.00 |
| Dec 31, 2021 | -432.00 |
| Sep 30, 2021 | 456.00 |